APA (7th ed.) Citation

Tada, M., Matsumoto, Y., Koike, T., Mamoto, K., Nakamura, T., Anno, S., . . . Hidaka, N. (2024). Biologic and targeted synthetic disease‐modifying anti‐rheumatic drugs improve body composition in rheumatoid arthritis patients more than conventional synthetic disease‐modifying anti‐rheumatic drugs: Results from the PRESENT study. International Journal of Rheumatic Diseases, 27(10), 1. https://doi.org/10.1111/1756-185X.15371

Chicago Style (17th ed.) Citation

Tada, Masahiro, Yoshinari Matsumoto, Tatsuya Koike, Kenji Mamoto, Tomoyuki Nakamura, Shohei Anno, Takahiro Iida, Hitoshi Goto, and Noriaki Hidaka. "Biologic and Targeted Synthetic Disease‐modifying Anti‐rheumatic Drugs Improve Body Composition in Rheumatoid Arthritis Patients More than Conventional Synthetic Disease‐modifying Anti‐rheumatic Drugs: Results from the PRESENT Study." International Journal of Rheumatic Diseases 27, no. 10 (2024): 1. https://doi.org/10.1111/1756-185X.15371.

MLA (9th ed.) Citation

Tada, Masahiro, et al. "Biologic and Targeted Synthetic Disease‐modifying Anti‐rheumatic Drugs Improve Body Composition in Rheumatoid Arthritis Patients More than Conventional Synthetic Disease‐modifying Anti‐rheumatic Drugs: Results from the PRESENT Study." International Journal of Rheumatic Diseases, vol. 27, no. 10, 2024, p. 1, https://doi.org/10.1111/1756-185X.15371.